The stock is known to soar on good news.

Dyne pursues rare disease breakthroughs while Vertex leverages blockbuster profits for pipeline expansion, how do their risk ...

Investors are growing more optimistic over the company's pipeline and the initiation of a Phase 1 trial with a new drug.

Sales of Eli Lilly's (NYSE: LLY) Mounjaro and Zepbound have been nothing short of amazing. The two GLP-1 drugs saw sales increases of 99% and 175%, respectively, in 2025. The company is at the ...

Goldman Sachs estimates that AI drug discovery and breakthroughs like gene editing will add 0.5% to 2.5% to the U.S. gross ...

GLP‑1 and next‑generation obesity drugs are gaining traction across the U.S. and globally, which is good news for investors.

View Bright Minds Biosciences Inc. DRUG stock quote prices, financial information, real-time forecasts, and company news from CNN.

Unicyive Therapeutics is awaiting word on whether its main drug, oxylanthanum carbonate, will be approved to treat ...

Veeva Systems markets a suite of software services geared toward the biopharmaceutical industry. A wholly owned customer relationship management service is gaining steam for Veeva Systems. With access ...

Abivax will continue to march higher thanks to positive data on its ulcerative colitis treatment, according to Jefferies.

Every weekday, the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" livestream at 10:20 a.m. ET. Here's a recap of Friday's key moments. 1. The S & P 500 turned higher Friday. The index ...